Maravai Lifesciences Holdings annual current ratio
2020
2021
2022
2023
2024
2025
Maravai Lifesciences Holdings Current Ratio Growth & History (MRVI)
Maravai Lifesciences Holdings's current ratio was 6.60 for fiscal 2025.
View full Maravai Lifesciences Holdings company overviewMaravai Lifesciences Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 6.60 | −0.94 | −12.44% |
| 2024 | 2024-12-31 | 7.53 | −0.47 | −5.86% |
| 2023 | 2023-12-31 | 8.00 | 0.30 | +3.95% |
| 2022 | 2022-12-31 | 7.70 | −0.19 | −2.45% |
| 2021 | 2021-12-31 | 7.89 | 5.36 | +211.23% |
| 2020 | 2020-12-31 | 2.54 | — | — |
Maravai Lifesciences Holdings quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 4.05 | −1.11 | −21.53% |
| Q1 2026 | 2026-03-31 | 5.91 | −0.05 | −0.87% |
| Q4 2025 | 2025-12-31 | 6.60 | −0.94 | −12.44% |
| Q3 2025 | 2025-09-30 | 5.29 | −5.37 | −50.35% |
| Q2 2025 | 2025-06-30 | 5.16 | −4.77 | −48.02% |
| Q1 2025 | 2025-03-31 | 5.96 | −5.36 | −47.35% |
| Q4 2024 | 2024-12-31 | 7.53 | −0.47 | −5.86% |
| Q3 2024 | 2024-09-30 | 10.66 | 1.70 | +19.02% |
| Q2 2024 | 2024-06-30 | 9.93 | 0.60 | +6.40% |
| Q1 2024 | 2024-03-31 | 11.32 | 5.19 | +84.62% |
| Q4 2023 | 2023-12-31 | 8.00 | 0.30 | +3.95% |
| Q3 2023 | 2023-09-30 | 8.96 | 1.73 | +23.98% |
| Q2 2023 | 2023-06-30 | 9.33 | 2.59 | +38.32% |
| Q1 2023 | 2023-03-31 | 6.13 | −1.01 | −14.20% |
| Q4 2022 | 2022-12-31 | 7.70 | −0.19 | −2.45% |
| Q3 2022 | 2022-09-30 | 7.22 | 1.21 | +20.17% |
| Q2 2022 | 2022-06-30 | 6.75 | 2.84 | +72.53% |
| Q1 2022 | 2022-03-31 | 7.14 | 4.57 | +177.39% |
| Q4 2021 | 2021-12-31 | 7.89 | 5.36 | +211.23% |
| Q3 2021 | 2021-09-30 | 6.01 | — | — |
| Q2 2021 | 2021-06-30 | 3.91 | — | — |
| Q1 2021 | 2021-03-31 | 2.58 | — | — |
| Q4 2020 | 2020-12-31 | 2.54 | — | — |
Maravai Lifesciences Holdings current ratio trends
Over the last five fiscal years, Maravai Lifesciences Holdings's current ratio increased from 2.54 to 6.60, a change of 4.06. The latest reported quarter, Q2 2026, shows 4.05.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maravai Lifesciences Holdings source filings ↗